Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

SHE:002864 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,230	1,095	1,169	1,102	823.44	419.3
Cash & Short-Term Investments	1,230	1,095	1,169	1,102	823.44	419.3
Cash Growth	5.53%	-6.37%	6.11%	33.83%	96.38%	9.77%
Accounts Receivable	531.21	547.28	494.59	476.42	538.41	446.38
Other Receivables	7.98	10.07	2.12	3.07	2.13	2.55
Receivables	539.19	557.35	496.71	479.49	540.54	448.93
Inventory	117.34	110.82	95.58	77.63	94.63	66.77
Other Current Assets	31.43	39.71	9.86	18.67	23.33	21.45
Total Current Assets	1,918	1,803	1,772	1,678	1,482	956.45
Property, Plant & Equipment	431.24	439.04	438.21	371.7	353.74	275.04
Long-Term Investments	10.02	10.08	10.21	9.71	9.89	-
Other Intangible Assets	49.75	50.13	51.35	52.76	54.9	56.33
Long-Term Deferred Tax Assets	12.03	9.35	4.89	7.22	16.63	20.2
Long-Term Deferred Charges	4.25	4.39	3.12	2.87	1.31	0.02
Other Long-Term Assets	7.03	7.03	0.71	2.96	12.36	22.13
Total Assets	2,432	2,323	2,280	2,125	1,931	1,330

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	132.64	127.57	107.92	91.43	121.67	66.01
Accrued Expenses	12.38	194.74	187.96	181.38	215.43	176.72
Short-Term Debt	50	-	50	100	150.46	87.2
Current Portion of Long-Term Debt	0.84	98.5	1	-	247.62	13
Current Portion of Leases	-	0.38	0.31	0.39	1.41	2.03
Current Income Taxes Payable	24.77	10.52	8.66	9.11	14.73	17.21
Current Unearned Revenue	8.07	4.21	3.68	5.53	13.26	4.7
Other Current Liabilities	281.24	88.23	86.59	92.57	138.11	70.69
Total Current Liabilities	509.95	524.15	446.11	480.41	902.68	437.55
Long-Term Debt	100	-	98.5	-	27.35	40.35
Long-Term Leases	1.51	1.95	2.33	2.11	0.33	1.32
Long-Term Unearned Revenue	110.18	107.65	95.9	91.25	52.83	41.4
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.35
Total Liabilities	721.64	633.75	642.84	573.76	983.18	522.97

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	106.28	106.28	106.28	106.28	86.71	86.67
Additional Paid-In Capital	813.9	813.9	816.64	817.78	259.43	271.67
Retained Earnings	813.49	791.73	737.25	640.06	548.96	463.19
Treasury Stock	-25.08	-25.08	-24.95	-15.07	-15.07	-30.15
Comprehensive Income & Other	-	-	-	-	49.62	-
Total Common Equity	1,709	1,687	1,635	1,549	929.65	791.38
Minority Interest	2.17	2.2	1.97	2.21	17.95	15.82
Shareholders' Equity	1,711	1,689	1,637	1,551	947.6	807.21
Total Liabilities & Equity	2,432	2,323	2,280	2,125	1,931	1,330

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	152.35	100.83	152.14	102.49	427.16	143.9
Net Cash (Debt)	1,078	994.06	1,017	999.52	396.28	275.41
Net Cash Growth	6.24%	-2.28%	1.77%	152.22%	43.89%	-1.78%
Net Cash Per Share	7.93	7.31	7.48	7.87	3.53	2.48
Filing Date Shares Outstanding	134.74	137.68	137.68	136.7	124.54	111.21
Total Common Shares Outstanding	134.74	137.68	137.68	136.7	111.26	111.21
Working Capital	1,408	1,279	1,325	1,197	579.27	518.89
Book Value Per Share	12.68	12.25	11.88	11.33	8.36	7.12
Tangible Book Value	1,659	1,637	1,584	1,496	874.75	735.05
Tangible Book Value Per Share	12.31	11.89	11.50	10.95	7.86	6.61
Buildings	-	447.01	398.37	331.9	329.36	152.82
Machinery	-	176.05	144.4	134.72	125.41	60.38
Construction In Progress	-	6.75	56.05	29.31	3.85	152.18

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error